Shanghai Allist Pharmaceuticals Co., Ltd was founded in March, 2004. It is an innovation-oriented drug developer, producer and seller dedicated to oncotherapy that targets the demand of the global pharmaceutical market. With the philosophy of “advancing long life with innovation of science and technology”, its primary mission is to create first-in-class and best-in-class medicines. After 17 years of unremitting efforts, Allist now enjoys comprehensive competitiveness, particularly the ability to develop the best anti-tumor drugs in the market with proved effect, in which it owns independent intellectual property rights. On December 2, 2020, Shanghai Allist Pharmaceuticals Co., Ltd was listed on the STAR board of Shanghai Stock Exchange (Stock code: 688578).